Publication | Open Access

In vitro cross-resistance and collateral sensitivity in seven resistant small-cell lung cancer cell lines: preclinical identification of suitable drug partners to taxotere, taxol, topotecan and gemcitabin

OncologyMedicineImmune Checkpoint InhibitorAnti-cancer AgentCancer TreatmentLung CancerSuitable Drug PartnersPharmacologyCell BiologyVitro Cross-resistanceTumor MicroenvironmentTumor BiologyCollateral SensitivityDrug Resistance